Abstract
(Abstracted from Hum Reprod 2019;34(4):758–769) The development of preimplantation genetic testing (PGT-A) in conjunction with assisted reproductive technology has led to valuable analysis of the high frequency of chromosomal abnormalities observed in human embryos. While mosaic embryos may lead to healthy live births, the likelihood of poor clinical outcomes is much greater when compared with euploid blastocyst development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
